1-20 of 166
Sort by
News

Drawing First Blood: Will Menin Inhibitors Revolutionize the Treatment of AML?

Leah Lawrence
Published: 2024
Abstract
October 2024
View News titled, Drawing First Blood: Will Menin Inhibitors Revolutionize the Treatment of AML?
News

Study Examines Development of Paraparesis, Quadriparesis in Pediatric Patients With B-ALL Treated With CAR T-Cell Therapy

Anna Azvolinsky, PhD
Published: 2024
Abstract
September 2024
View News titled, Study Examines Development of Paraparesis, Quadriparesis in Pediatric Patients With B-ALL Treated With CAR T-Cell Therapy
News

Dose-Adjusted VEN-HMA Regimens Safe, Effective in Very Old Patients With AML

Leah Lawrence
Published: 2024
Abstract
August 2024
View News titled, Dose-Adjusted VEN-HMA Regimens Safe, Effective in Very Old Patients With AML
News

Straight-to-Transplantation Approach Comparable to Remission Induction in Difficult Acute Myeloid Leukemia Cases

Thomas R. Collins
Published: 2024
Abstract
Mid-July 2024
View News titled, Straight-to-Transplantation Approach Comparable to Remission Induction in Difficult Acute Myeloid Leukemia Cases
News

ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia

Khylia Marshall
Published: 2024
Abstract
Mid-July 2024
View News titled, ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia
News

Which Inhibitor Should Be Used to Treat FLT3-Positive AML?

Emma Yasinski
Published: 2024
Abstract
July 2024
View News titled, Which Inhibitor Should Be Used to Treat FLT3-Positive AML?
News

Efficacy of PTCy Raises Doubts About the Importance of HLA Matching in AlloHCT

Khylia Marshall
Published: 2024
Abstract
June 2024
View News titled, Efficacy of PTCy Raises Doubts About the Importance of HLA Matching in AlloHCT
News

Gilteritinib Effective for Post-Transplant Maintenance for Acute Myeloid Leukemia

Lara C. Pullen, PhD
Published: 2024
Abstract
June 2024
View News titled, Gilteritinib Effective for Post-Transplant Maintenance for Acute Myeloid Leukemia
News

FLT3-Mutated AML Responds Favorably to Triplet Regimen Including Inhibitor

Khylia Marshall
Published: 2024
Abstract
May 2024
View News titled, FLT3-Mutated AML Responds Favorably to Triplet Regimen Including Inhibitor
News

Molecular MRD Testing Identifies Patients with NPM1mut AML Who May Benefit From Allogeneic Transplant

Lara C. Pullen, PhD
Published: 2024
Abstract
May 2024
View News titled, Molecular MRD Testing Identifies Patients with NPM1<sup>mut</sup> AML Who May Benefit From Allogeneic Transplant
News

Adults With Acute Myeloid Leukemia Follow One of Four Trajectories of Physical Well-Being

Lara C. Pullen, PhD
Published: 2024
Abstract
May 2024
View News titled, Adults With Acute Myeloid Leukemia Follow One of Four Trajectories of Physical Well-Being
News

Unique Molecular Subtypes within BCR::ABL1-Postive ALL Show Prognostic Relevance

Khylia Marshall
Published: 2024
Abstract
March 2024
View News titled, Unique Molecular Subtypes within BCR::ABL1-Postive ALL Show Prognostic Relevance
News

IKZF1 Alterations an Independent Marker of AML Risk

Leah Lawrence
Published: 2024
Abstract
February 2024
View News titled, IKZF1 Alterations an Independent Marker of AML Risk
News

Inotuzumab as a Bridging Therapy to Eradicate MRD Improves OS in Patients With ALL

Khylia Marshall
Published: 2024
Abstract
February 2024
View News titled, Inotuzumab as a Bridging Therapy to Eradicate MRD Improves OS in Patients With ALL
News

Triple-Combination Regimen of Quizartinib, Venetoclax, and Decitabine Effective in Patients with FLT3-ITD Mutated AML

Anna Azvolinsky, PhD
Published: 2023
Abstract
January 2024
View News titled, Triple-Combination Regimen of Quizartinib, Venetoclax, and Decitabine Effective in Patients with FLT3-ITD Mutated AML
News

Venetoclax Combo Delays Transformation to AML But Does Not Improve Survival in Patients with CMML

Anna Azvolinsky, PhD
Published: 2023
Abstract
January 2024
View News titled, Venetoclax Combo Delays Transformation to AML But Does Not Improve Survival in Patients with CMML
News

Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML

Leah Lawrence
Published: 2023
Abstract
December 2023
View News titled, Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML
News

HLA-Haploidentical Transplantation in Pediatric Acute Leukemia Offers Alternative to Matched Donor

Deborah Levenson
Published: 2023
Abstract
December 2023
View News titled, HLA-Haploidentical Transplantation in Pediatric Acute Leukemia Offers Alternative to Matched Donor
News

TP53 Status May Hint at Acute Myeloid Leukemia Prognosis

Lara C. Pullen, PhD
Published: 2023
Abstract
Mid-November 2023
View News titled, TP53 Status May Hint at Acute Myeloid Leukemia Prognosis
News

Children With T-ALL Show Similar Treatment Outcomes Independent of ETP Status

Katie Robinson
Published: 2023
Abstract
November 2023
View News titled, Children With T-ALL Show Similar Treatment Outcomes Independent of ETP Status